EF - 医索

找到约 499 条结果

Safety and efficacy of osimertinib plus consolidativestereotactic ablative radiation(SABR) inadvanced EGFR mutant non-small cell lungcancer(NSCLC)results from a multi-center Phase ltrial

医客学院 - 会议报告集

Niraparib and Dostarlimab efficacy in patients with platinum.sensitive relapsed mesothelioma MlST5, a phase lla clinicaltrial

医客学院 - 会议报告集

EFFICACY AND SAFETY OF TALETRECTINIB INPATIENTS WITH ADVANCED OR METASTATICROS1 NON-SMALL CELL LUNG CANCER THEPHASE 2 TRUST-I STUDY

医客学院 - 会议报告集

EFFICACY AND SAFETY OF SIGVOTATUGVEDOTIN, AN INVESTIGATIONAL ADC, IN NSCLCUPDATED PHASE 1 RESULTS(SGNB6A-001)

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

Can We Enhance the Benefit ofImmunotherapy in Non-Small CelLung Cancer

医客学院 - 会议报告集

Nivolumab plus ipilimumab vs chemotherapy as first-linetreatment for microsatellite instability-highmismatchrepairdeficient metastatic colorectal cancer expandedefficacy analysis from CheckMate 8HW

医客学院 - 会议报告集

Neoadjuvant treatment of lBl310 (anti-CTLA-4 antibody) plus sintilimab(anti-PD.1 antibody) in patients with microsatellite instabilityhighmismatchrepair-deficient colon cancer Results from a randomiz

医客学院 - 会议报告集

Neoadiuvant Pembrolizumab stratified to tumourmutation burden for High-Risk Stage 2 or Stage 3deficient-MMRMSl-High Colorectal CancerThe multicentre Phase 2 NEOPRISM-CRC trial

医客学院 - 会议报告集

Liver Transplantation and chemotherapy versusChemotherapy alone in patients with definitivelyunresectable colorectal liver metastases results from aprospective multicentre ran

医客学院 - 会议报告集

今日实时热搜